15897558 |
In vivo target modulation and biological activity of CHIR-258, a multitargeted growth factor receptor kinase inhibitor, in colon cancer models
Aukerman, SL,
Garrett, E,
Lee, SH,
Ye, H,
Gelb, AB,
Lopes de Menezes, D,
Samara, E,
Harris, A,
Heise, C,
Nordahl, L,
Vora, J
|
Clin Cancer Res |
2005 |
18381947 |
A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors
Garzon, F,
Molife, R,
Michelson, G,
de Bono, JS,
Morrison, R,
Hardie, M,
Heise, C,
Aziz, N,
Jadayel, D,
Judson, IR,
Braendle, E,
Sarker, D,
Butzberger-Zimmerli, P,
Louie, S,
Evans, TR,
Marriott, C,
Fox, JA
|
Clin Cancer Res |
2008 |